FDA Approved: EYSUVIS — Original Application (ALCON LABORATORIES, INC.)

View source ↗

Summary

FDA approved EYSUVIS (loteprednol etabonate) ophthalmic suspension from Alcon for short-term treatment of ocular inflammation after ocular surgery, via the orig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation

Drugs mentioned

• EYSUVIS (loteprednol etabonate)

Snippet

ORIG AP for EYSUVIS (LOTEPREDNOL ETABONATE)